Haichuan Su

2.4k total citations
46 papers, 814 citations indexed

About

Haichuan Su is a scholar working on Molecular Biology, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Haichuan Su has authored 46 papers receiving a total of 814 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Molecular Biology, 18 papers in Oncology and 9 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Haichuan Su's work include RNA modifications and cancer (10 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Haichuan Su is often cited by papers focused on RNA modifications and cancer (10 papers), Pancreatic and Hepatic Oncology Research (6 papers) and Lung Cancer Treatments and Mutations (4 papers). Haichuan Su collaborates with scholars based in China and United States. Haichuan Su's co-authors include Yang Song, Daxiang Cui, Jun Chen, Ronglin Wang, Xiao Zhi, Jing Yang, Yong Zhang, Peng Zhao, Xuejun Zhu and Peixiang Ma and has published in prestigious journals such as Journal of Clinical Oncology, PLoS ONE and Cancer Research.

In The Last Decade

Haichuan Su

43 papers receiving 800 citations

Peers

Haichuan Su

ONCOL

PRM

Chengjun Li China

Yuki Yokota Japan

Linwei Li China

Y Miyamoto Japan

Lijun Zhou China

Saïda Mebarek France

Dawei Xu China

Mehrdad A. Estiar Iran

Martina Bartolucci Italy

Chengjun Li China

Haichuan Su

639 ×1.7

168 ×0.8

79 ×0.7

ONCOL

89 ×0.8

PRM

73 ×0.8

Citations per year, relative to Haichuan Su Haichuan Su (= 1×) peers Chengjun Li

Countries citing papers authored by Haichuan Su

Since Specialization

Citations

This map shows the geographic impact of Haichuan Su's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Haichuan Su with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Haichuan Su more than expected).

Fields of papers citing papers by Haichuan Su

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Haichuan Su. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Haichuan Su. The network helps show where Haichuan Su may publish in the future.

Co-authorship network of co-authors of Haichuan Su

This figure shows the co-authorship network connecting the top 25 collaborators of Haichuan Su. A scholar is included among the top collaborators of Haichuan Su based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Haichuan Su. Haichuan Su is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Liu, Jingyi, et al.. (2025). Research progress on HER2-specific chimeric antigen receptor T cells for immunotherapy of solid tumors. Frontiers in Immunology. 16. 1514994–1514994. 2 indexed citations

Deng, Linhong, Jingyi Ren, Hong Li, et al.. (2025). Ran drives pancreatic cancer metastasis by activating the osteopontin-PI3K/AKT-androgen receptor signaling cascade. Toxicology and Applied Pharmacology. 499. 117328–117328.

Li, Quan, Junqiang Li, Ronglin Wang, et al.. (2025). The type I collagen paradox in PDAC progression: microenvironmental protector turned tumor accomplice. Journal of Translational Medicine. 23(1). 744–744. 2 indexed citations

Wan, Zhuo, Cheng Yang, Ronglin Wang, et al.. (2024). Advances and clinical challenges of mesenchymal stem cell therapy. Frontiers in Immunology. 15. 1421854–1421854. 25 indexed citations

Zhou, Feng, et al.. (2024). Potential Mechanisms of Hexaconazole Resistance in Fusarium graminearum. Plant Disease. 108(10). 3133–3145. 3 indexed citations

Yang, Cheng, et al.. (2024). METTL3-mediated RanGAP1 promotes colorectal cancer progression through the MAPK pathway by recruiting YTHDF1. Cancer Gene Therapy. 31(4). 562–573. 7 indexed citations

Su, Haichuan, et al.. (2023). A bioequivalence study of trifluridine/tipiracil tablets in Chinese metastatic colorectal cancer patients under fed conditions. Cancer Chemotherapy and Pharmacology. 91(2). 167–177. 1 indexed citations

Wang, Ronglin, Cheng Yang, Peixiang Ma, et al.. (2023). Machine learning-based integration develops a metabolism-derived consensus model for improving immunotherapy in pancreatic cancer. Journal for ImmunoTherapy of Cancer. 11(9). e007466–e007466. 9 indexed citations

Liu, Lili, Tao Zhang, Cheng‐Gong Liao, et al.. (2023). Hyperthermic intrathoracic/intraperitoneal chemotherapy versus conventional intrapleural/intraperitoneal chemotherapy for the malignant effusion: a multi-center randomized clinical trial. International Journal of Hyperthermia. 40(1). 2241689–2241689. 1 indexed citations

10.

Zhang, Changgong, Liying Gao, Chunmei Bai, et al.. (2022). Penpulimab plus anlotinib in patients with recurrent or metastatic head and neck squamous cell carcinoma after the failure of first-line platinum-based chemotherapy: A single-arm, multicenter, phase 2 study.. Journal of Clinical Oncology. 40(16_suppl). 6027–6027. 1 indexed citations

11.

Wang, Ronglin, Peixiang Ma, Yang Song, et al.. (2022). Comprehensive Analysis of 5-Methylcytosine (m5C) Regulators and the Immune Microenvironment in Pancreatic Adenocarcinoma to Aid Immunotherapy. Frontiers in Oncology. 12. 851766–851766. 7 indexed citations

12.

Zhang, Chao, Junqiang Li, Ronglin Wang, et al.. (2021). Ese-3 Inhibits the Proliferation, Migration, and Invasion of HaCaT Cells by Downregulating PSIP1 and NUCKS1.. 51(4). 470–486. 3 indexed citations

13.

Wang, Ronglin, Junqiang Li, Yang Song, et al.. (2021). Comprehensive Analysis of m6A RNA Methylation Regulators and the Immune Microenvironment to Aid Immunotherapy in Pancreatic Cancer. Frontiers in Immunology. 12. 769425–769425. 24 indexed citations

14.

Zhi, Xiao, Haichuan Su, Kan Wang, et al.. (2015). A Novel Electrochemical Microfluidic Chip Combined with Multiple Biomarkers for Early Diagnosis of Gastric Cancer. Nanoscale Research Letters. 10(1). 477–477. 61 indexed citations

15.

Zhang, Jingpu, Yang Song, Chunlei Zhang, et al.. (2015). Circulating MiR-16-5p and MiR-19b-3p as Two Novel Potential Biomarkers to Indicate Progression of Gastric Cancer. Theranostics. 5(7). 733–745. 131 indexed citations

16.

Mu, Nan, Nannan Liu, Qiang Hao, et al.. (2014). Inhibition of mouse SP2/0 myeloma cell growth by the B7-H4 protein vaccine. BMB Reports. 47(7). 399–404. 3 indexed citations

17.

Liu, Boya, Qingchun Liu, Yang Song, et al.. (2014). Polymorphisms of HIF1A gene are associated with prognosis of early stage non-small-cell lung cancer patients after surgery. Medical Oncology. 31(4). 877–877. 16 indexed citations

18.

Chen, Jun, Yang Song, Jing Yang, et al.. (2013). The up-regulation of cysteine-rich protein 61 induced by transforming growth factor beta enhances osteosarcoma cell migration. Molecular and Cellular Biochemistry. 384(1-2). 269–277. 14 indexed citations

19.

Li, Weina, Yang Song, Lili Wang, et al.. (2013). Growth Differentiation Factor-15 Suppresses Maturation and Function of Dendritic Cells and Inhibits Tumor-Specific Immune Response. PLoS ONE. 8(11). e78618–e78618. 61 indexed citations

20.

Liu, Lili, Jie Min, Junwei Wang, et al.. (2011). The effect of down regulation of calcineurin Aα by lentiviral vector-mediated RNAi on the biological behavior of small-cell lung cancer and its bone metastasis. Clinical & Experimental Metastasis. 28(8). 765–778. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact